E

EBR Systems Inc
ASX:EBR

Watchlist Manager
EBR Systems Inc
ASX:EBR
Watchlist
Price: 0.735 AUD -2.65% Market Closed
Market Cap: AU$330.8m

EBR Systems Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

EBR Systems Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
E
EBR Systems Inc
ASX:EBR
Research & Development
-$13.2m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Research & Development
-$2.1B
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Research & Development
-$1.6B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.8B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
-8%
IDEXX Laboratories Inc
NASDAQ:IDXX
Research & Development
-$251.2m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-10%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.3B
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-21%
No Stocks Found

EBR Systems Inc
Glance View

Market Cap
330.8m AUD
Industry
Health Care

EBR Systems, Inc. engages in the development of implantable systems for wireless tissue stimulation. The company is headquartered in Sunnyvale, California. The company went IPO on 2021-11-24. The firm is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The firm also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The firm operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.

EBR Intrinsic Value
Not Available

See Also

What is EBR Systems Inc's Research & Development?
Research & Development
-13.2m USD

Based on the financial report for Dec 31, 2022, EBR Systems Inc's Research & Development amounts to -13.2m USD.

What is EBR Systems Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-6%

Over the last year, the Research & Development growth was -83%. The average annual Research & Development growth rates for EBR Systems Inc have been -6% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett